Abstract:Objective To investigate the effects of adenosine monophosphate activated protein kinase(AMPK) regulated autophagy on restoring the sensitivity of diabetic myocardium to ischemic postconditioning(IPO). Methods Healthy male Sprague-Dawley rats(weighed 220-280 g) were used in this study. Thirty healthy rats were randomly divided into:sham group (N+S group), ischemia reperfusion group (N+IR group) and ischemia postconditionig group(N+IPO group);type 1 diabetic rat models were induced by a single intraperitoneal injection of streptozotocin at the dose of 60 mg/kg and confirmed by blood glucose concentration≥16.7 mmol/L;all rats were raised for 8 weeks. Fifty-four diabetic rats were randomly assigned into diabetic sham group (D + S group), diabetic ischemia group(D + IR group), diabetic ischemia postconditionig group(D+IPO group), diabetic ischemia+AMPK activtor A-769662 group(D+IR+A group), diabetic ischemia postconditionig+A-769662 group(D+IPO+A group). There were 6 rats in N+S and D+S group and 12 rats each in the other groups. Myocardial ischemia reperfusion model was completed by occlusion of the anterior descending branch of left coronary artery for 30 min followed by 120 min of reperfusion. IPO was induced by 3 cycles of 10 second of reperfusion and ischemia at the onset of reperfusion. AMPK agonist A-769662(6 mg/kg) was given as intraperitoneal injection 30 min before ischemia. Myocardium infarct size (IS) was detected by triphenyltetrazolium chloride staining. Transmission electron microscopeserum was used to observe autophagosomes. Arterial blood was collected to detect creatine kinase-MB(CK-MB) and lactate dehydrogenase(LDH) release. The phosphorylation of AMPK (p-AMPK) and mammalian target of rapamycin (p-mTOR), the ratio of microtubule-associated protein 1 light chain 3B/A(LC3B/A) and ubiquitin binding protein p62 in heart tissues were examined by Western blotting. The t test was adopted to detect the differences between two groups, one-way analysis of variance was used to analyze the differences between groups. Results Diabetic rats characterized with lower body weight, p-AMPK expression, autophagosomes number and LC3B/A ratio and higher CK-MB, LDH, p-mTOR, p62 and blood glucose when compared with nondiabetic rats(t=4.15-34.65, all P<0.05). Compared with N+IR group, the level of IS, CK-MB, LDH in D+IR group increased significantly(t=3.55, 4.70, 7.20, all P<0.05). Compared with N+S group, p-AMPK level, autophagosomes number and LC3B/A ratio significantly increased, p-mTOR and p62 expressions remarkably deceased in N+IR group(t=6.56, 5.51, 3.76, 3.59, 2.98, all P<0.05);while those changes were not found between D+S and D+IR group (all P>0.05). Compared with D+IR group, the IS(28%±5%vs 45%±6%), CK-MB((1 047±178) vs (2 050±325) U/L), LDH((1 303±365) vs (2 558±189) U/L), p-mTOR(0.48±0.24 vs 1.29±0.25), p62(0.74±0.12 vs 1.04±0.24) decreased significantly, and the p-AMPK level(1.81±0.19 vs 0.61±0.15), autophagosomes number(9.3±1.4 vs 3.8±0.9) and LC3B/A ratio (1.43 ± 0.23 vs 0.65 ± 0.13) increased significantly in D+IPO+A group (t=5.26-11.82, all P<0.05). Conclusion AMPK/mTOR activation by A-769662 can restore the sensitivity of diabetic hearts to IPO-induced cardioprotection through autophagy promotion.

The Protective Effect of 11-Keto-β-Boswellic Acid against Diabetic Cardiomyopathy in Rats Entails Activation of AMPK

AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis

The Protective Effect of Bone Marrow Mesenchymal Stem Cells by Anoxic Preconditioning on Diabetic Cardiomyopathy

A Novel Protective Mechanism for Mitochondrial Aldehyde Dehydrogenase (aldh2) in Type I Diabetes-Induced Cardiac Dysfunction: Role of Ampk-Regulated Autophagy

Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway

Cardamomin Protects from Diabetes-Induced Kidney Damage Through Modulating PI3K/AKT and JAK/STAT Signaling Pathways in Rats.

Effects of Adenosine Monophosphate Activated Protein Kinase Regulated Autophagy on Restoring the Sensitivity of Diabetic Myocardium to Ischemic Postconditioning

Berberine Treatment Prevents Cardiac Dysfunction and Remodeling Through Activation of 5′-Adenosine Monophosphate-Activated Protein Kinase in Type 2 Diabetic Rats and in Palmitate-Induced Hypertrophic H9c2 Cells

UCF-101 Mitigates Streptozotocin-Induced Cardiomyocyte Dysfunction: Role of AMPK

Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function

Effects of kaempherol-3-rhamnoside on metabolic enzymes and AMPK in the liver tissue of STZ-induced diabetes in mice

Ketogenic diet modulates cardiac metabolic dysregulation in streptozocin-induced diabetic rats

Effects of Early Intervention of Didang Decoction on AMP-activated Protein Kinase Signaling Pathway in Diabetic Rats

The Protective Effect Of Beraprost Sodium On Diabetic Cardiomyopathy Through The Inhibition Of The P38 Mapk Signaling Pathway In High-Fat-Induced Sd Rats

Cardioprotective Effects of Asiaticoside Against Diabetic Cardiomyopathy: Activation of the AMPK/Nrf2 Pathway.

Novel regulation of cardiac branched-chain amino acid metabolism through AMP deaminase: a possible therapeutic target for diabetic cardiomyopathy

Cardamonin Protects Against Diabetic Cardiomyopathy by Activating Macrophage NRF2 Signaling Through Molecular Interaction with KEAP1.

Molecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol

Asiatic acid protects hearts and relative mitochondria of streptozotocin-induced diabetic rats

The protective effect of oleanolic acid on diabetic myocardium of rats and its mechanism

A Beneficial Role of Caffeic Acid on Cardiovascular Complication Associated with Type-1 Diabetes Mellitus in Rats